Man Group
CYTK icon

Man Group’s Cytokinetics CYTK Stock Holding History

Man Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
17,393
+6,930
+66% +$498K ﹤0.01% 1703
2026
Q1 		$690K Sell
10,463
-1,124
-10% -$71.4K ﹤0.01% 1967
2025
Q4 		$736K Buy
+11,587
New +$721K ﹤0.01% 1775
2025
Q1 		– Sell
-63,696
Closed -$3M – 2212
2024
Q4 		$3M Sell
63,696
-238,517
-79% -$12.4M 0.01% 1193
2024
Q3 		$16M Buy
302,213
+227,074
+302% +$12.7M 0.04% 531
2024
Q2 		$4.07M Sell
75,139
-7,505
-9% -$453K 0.01% 1094
2024
Q1 		$5.79M Buy
82,644
+74,357
+897% +$5.75M 0.01% 943
2023
Q4 		$692K Buy
+8,287
New +$300K ﹤0.01% 1567
2023
Q3 		– Sell
-244,107
Closed -$8.13M – 1644
2023
Q2 		$7.96M Buy
+244,107
New +$9.03M 0.02% 706
2023
Q1 		– Hold
0
– – – 913
2022
Q2 		– Sell
-52,653
Closed -$2.12M – 939
2022
Q1 		$1.94M Buy
+52,653
New +$1.87M 0.01% 1221
2019
Q1 		– Sell
-11,100
Closed -$70K – 1974
2018
Q4 		$70K Sell
11,100
-2,300
-17% -$16.9K ﹤0.01% 1869
2018
Q3 		$132K Sell
13,400
-4,900
-27% -$39.3K ﹤0.01% 2045
2018
Q2 		$152K Sell
18,300
-34,200
-65% -$285K ﹤0.01% 2047
2018
Q1 		$378K Buy
+52,500
New +$450K ﹤0.01% 1778

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's CYTK Position: Q2 2026 in Review

Man Group increased its Cytokinetics (CYTK) stake by 66% in Q2 2026, buying an estimated $498K and bringing the position to 17,393 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Man Group first reported a position in CYTK in Q1 2018 and has held it in 14 quarters since. The position peaked at $16M in Q3 2024. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Man Group held 17,393 shares of Cytokinetics worth $1.48M as of Q2 2026.
  • Man Group bought 6,930 Cytokinetics shares in Q2 2026, an estimated $498K.
  • Cytokinetics made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1703 holding.
  • Man Group first reported a position in Cytokinetics in Q1 2018 and has held it in 14 quarters since.
  • Man Group's Cytokinetics position peaked at $16M in Q3 2024.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.